The fifth wave continues to decline in Spain and the incidence at 14 days has already led to a consecutive decline for three weeks. This Tuesday, infections per 100,000 inhabitants fell to 398.94, a drop of 16.96 points compared to Monday. This is a decrease of almost 300 infections of difference compared to the peak of 702 cases of this wave, registered on Tuesday, July 27.
The incidence increases slightly in Aragon and Murcia, as well as in Ceuta. In addition, the younger age groups continue to improve their indicators. Those from 20 to 29 drop from 800 points (769) and those from 12 to 19 drop to 854 cases per 100,000 inhabitants.
The Ministry of Health has reported 14,336 new infections in the last day. The data is comparable to that of last Friday, when 15,657 infections were reported, since all weekend cases are counted on Monday. In total, 4,733,602 people have been infected with COVID-19 since the beginning of the pandemic.
The communities that register the highest number of new infections are Andalusia, which reports 3,290; Madrid, with 1,955 new cases; and Catalonia, which totals 1,849.
The latest report on the epidemiological situation also reports 144 deaths registered in the last 24 hours. With today’s data, the deaths from COVID amount to 82,739.
Why your snot can become the barrier against COVID with the right vaccine
With the onset of the pandemic, the global scientific effort focused on investigating which drugs could treat COVID-19 and at the same time looking for a vaccine against the disease caused by the SARS-CoV-2 coronavirus. That was the initial objective in the face of thousands of deaths and an urgent epidemiological situation: to find a drug that would prevent the development of the disease and its consequences. Now, as the vaccination campaign in Spain progresses with 70% of the population with at least one dose, and taking into account that these products have demonstrated their effectiveness against the development of the condition, it is worth wondering what is the key to that the coronavirus does not enter the body. And the answer is mucosal immunity.
“The oral and respiratory mucosa is the fundamental entry point of the virus”, explains the doctor in epidemiology Antonio Gutiérrez. “If IgA antibodies are generated, they neutralize the pathogen just before entering the body, preventing infection to a large extent,” Gutiérrez clarifies. That is the idea of administering a nasal vaccine like the one developed at the CSIC’s National Center for Biotechnology.